<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00512694</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00008875</org_study_id>
    <secondary_id>8652-07-6R1</secondary_id>
    <nct_id>NCT00512694</nct_id>
  </id_info>
  <brief_title>Duke Lupus Registry</brief_title>
  <official_title>Duke Lupus Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lupus is a systemic autoimmune disease that can present with many varied symptoms, including&#xD;
      joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most&#xD;
      common in younger women.&#xD;
&#xD;
      The Duke Lupus Registry will collect information and blood samples from patients with lupus&#xD;
      (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The&#xD;
      goal of this Registry is to understand how lupus changes over time so that we can improve the&#xD;
      treatment of patients with lupus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Duke Lupus Registry is a prospective cohort comprised of patients with lupus seen in the&#xD;
      Duke Rheumatology clinic.&#xD;
&#xD;
      The Duke Lupus Registry has two main purposes:&#xD;
&#xD;
        1. Improved patient care. By following disease activity scores and medication usage, we&#xD;
           expect to improve our care of the patients seen in clinic.&#xD;
&#xD;
        2. Future research on lupus outcomes. This may encompass a broad array of areas, including&#xD;
           but not limited to cardiovascular health, pregnancy and fertility, infections,&#xD;
           medication use, quality of life, and depression.&#xD;
&#xD;
      At each office visit, patients will complete a questionnaire, physicians will measure lupus&#xD;
      activity, and patients may be asked to provide a small blood sample. Patients will not be&#xD;
      required to make extra visits to Duke in order to participate -- all paperwork and blood&#xD;
      draws will occur during a regularly scheduled office visit with the physician.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <condition>Cutaneous Lupus</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be collected for future research.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Any patients with lupus.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus&#xD;
&#xD;
          -  Patient of a rheumatologist at Duke University Medical Center&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to travel to Duke for follow-up visits&#xD;
&#xD;
          -  Inability to speak English&#xD;
&#xD;
          -  Not able to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Megan E. B. Clowse, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Neil</last_name>
    <phone>(919) 684-8936</phone>
    <email>laura.k.neil@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Tochacek, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Lisa G. Criscione-Schreiber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Megan E. B. Clowse, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.dukehealth.org/locations/duke_lupus_clinic</url>
    <description>The Duke Lupus Clinic website</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 6, 2007</study_first_submitted>
  <study_first_submitted_qc>August 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2007</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lupus</keyword>
  <keyword>Systemic Lupus Erythematosus</keyword>
  <keyword>Cutaneous Lupus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

